Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.

Cepheid has announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert™ MRSA test, which runs on the GeneXpert® System, for the detection of ...

SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This ...

Cepheid announced that it has received US FDA clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert Xpress MVP. This multiplex vaginal panel can now be performed in ...

The agreement significantly expands a longtime partnership between Cepheid - a Danaher operating company - and the Global Fund to improve access to testing where it matters most. Both Cepheid and the ...

SUNNYVALE, Calif. , Aug. 19, 2025 /CNW/ -- Cepheid today announced that Health Canada has issued Cepheid a medical device licence for Xpert ® HCV VL Fingerstick, an HCV RNA test that detects and ...

Cepheid has entered into a collaborative agreement with Takara Bio Inc. of Shiga, Japan, under which Cepheid will package and distribute a dry-formulated version of Takara's Taq HS polymerase product ...